Skip to content

Chlamydia widespread in China, adds to HIV risk

Cotrimoxazole prophylaxis

Starting HAART at CD4 above 350 does not give better T-cell response

AIDS dissident appointment `last straw` in battle of activists and South African Health Minister

Major PI-sparing study closes Trizivir arm due to inferiority to efavirenz arms

Adefovir approved for hepatitis B treatment in Europe

GPs missing signs of primary HIV infection in south London

Hepatitis not HAART causing serious liver toxicity in HIV patients

Diabetes risk increased threefold in HIV-positive women treated with PI